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The Journal of Immunology
Csf1r-mApple Transgene Expression and Ligand Binding
In Vivo Reveal Dynamics of CSF1R Expression within the
Mononuclear Phagocyte System
Catherine A. Hawley,*,1 Rocio Rojo,†,1 Anna Raper,†,1 Kristin A. Sauter,†
Zofia M. Lisowski,† Kathleen Grabert,† Calum C. Bain,* Gemma M. Davis,†,‡
Pieter A. Louwe,* Michael C. Ostrowski,x David A. Hume,*,†,{ Clare Pridans,*,† and
Stephen J. Jenkins*
CSF1 is the primary growth factor controlling macrophage numbers, but whether expression of the CSF1 receptor differs between
discrete populations of mononuclear phagocytes remains unclear. We have generated a Csf1r-mApple transgenic fluorescent
reporter mouse that, in combination with lineage tracing, Alexa Fluor 647–labeled CSF1-Fc and CSF1, and a modified DCsf1–
enhanced cyan fluorescent protein (ECFP) transgene that lacks a 150 bp segment of the distal promoter, we have used to dissect
the differentiation and CSF1 responsiveness of mononuclear phagocyte populations in situ. Consistent with previous Csf1r-driven
reporter lines, Csf1r-mApple was expressed in blood monocytes and at higher levels in tissue macrophages, and was readily
detectable in whole mounts or with multiphoton microscopy. In the liver and peritoneal cavity, uptake of labeled CSF1 largely
reflected transgene expression, with greater receptor activity in mature macrophages than monocytes and tissue-specific expres-
sion in conventional dendritic cells. However, CSF1 uptake also differed between subsets of monocytes and discrete populations of
tissue macrophages, which in macrophages correlated with their level of dependence on CSF1 receptor signaling for survival
rather than degree of transgene expression. A double DCsf1r-ECFP-Csf1r-mApple transgenic mouse distinguished subpopulations
of microglia in the brain, and permitted imaging of interstitial macrophages distinct from alveolar macrophages, and pulmonary
monocytes and conventional dendritic cells. The Csf1r-mApple mice and fluorescently labeled CSF1 will be valuable resources for
the study of macrophage and CSF1 biology, which are compatible with existing EGFP-based reporter lines. The Journal of
Immunology, 2018, 200: 000–000.
T
he mononuclear phagocyte system (MPS) is a family of
functionally related myeloid cells comprising progenitor
cells, monocytes, macrophages, and conventional den-
dritic cells (cDC) (1–5). Macrophages resident in tissues may be
derived from definitive hematopoiesis via circulating monocytes
or by self-renewal from cells seeded during embryonic or early
postnatal life (1, 2, 4, 5). cDCs have been classified as those cells
deriving from common dendritic cell (DC) progenitors via circu-
lating pre-DC (1, 6, 7). Regardless of their developmental origin,
macrophages and their precursors express the M-CSF receptor
CSF1R, and depend upon signals from two ligands, CSF1 or IL34,
for proliferation, differentiation, and survival (2, 3). Receptor-
mediated internalization and destruction of CSF1 controls its
availability (8) and provides a homeostatic control on macrophage
numbers (3). Accordingly, administration of recombinant CSF1
(9) or a more stable CSF1-Fc fusion protein (10–12) to mice
produces expansion of blood monocyte and tissue macrophage
populations, yet the degree to which CSF1R expression and ac-
tivity differ between populations of mononuclear phagocytes is
unclear.
cDC express high levels of a related tyrosine kinase receptor,
Fms-like tyrosine kinase 3 (Flt3). Their numbers are greatly in-
creased following treatment of mice with Flt3 ligand (Flt3L), and
depleted in Flt3L-deficient animals (7, 13–17). Two subsets of
cDC, cDC1 and cDC2, appear to differ in their expression of
Csf1r. cDC1 are not generally dependent upon CSF1 and lack
Csf1r mRNA (14). cDC2 have been more difficult to define be-
cause of major overlaps in cellular phenotype with other CD11b+
CD11c+MHC class II (MHCII)+ monocyte-derived APCs (18–20).
Genuine Flt3-dependent cDC2 of common DC progenitor origin
have been defined based upon migratory behavior and the lack of
the macrophage markers CD64 and F4/80 (6, 15, 21, 22). With
this definition, cDC2 in various tissues expressed lower levels of
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Csf1r mRNA than monocyte-derived APC (15, 22) and have been
considered CSF1R independent (1). The levels of surface CSF1R
largely distinguish Flt3L-dependent cDC2 from short-lived
monocyte-derived CD11c+/2 MHCII+ cells in the serous cavities
(23, 24). However, cDC2 isolated from spleen express high levels
of both Csf1r and Flt3 mRNA (www.biogps.org) and their num-
bers are controlled by CSF1 in vivo (25). Therefore, it remains
unclear whether there is a genuine dichotomy between Csf1r and
Flt3-dependent myeloid APC.
CSF1R on macrophages is continuously removed from the cell
surface by endocytosis and degraded following ligand binding. For
that reason, the detection of CSF1R protein by immunohisto-
chemistry or flow cytometry does not provide a clear indication of
functional expression. To identify Csf1r-expressing cells in situ,
regulatory elements of the murine Csf1r locus, including a 150 bp
segment of the distal promoter, were used to produce Csf1r-EGFP
reporter mice (26). The same promoter construct was used to
drive constitutive (27) and inducible cre-recombinase to support
macrophage-specific conditional mutations (28) as well as lineage
tracing (29), and these tools have been widely distributed among
the research community. However, new resources are required to
verify with single-cell resolution the extent to which Csf1r
transgene expression reflects that of functional CSF1R protein.
In addition to aiding our understanding of the regulation of
myeloid cells, visualization of Csf1r gene and protein expression
may also be useful to study cell interactions in vivo due to the lack
of tools to identify discrete MPS populations during multicolor
imaging. A binary enhanced cyan fluorescent protein (ECFP) re-
porter (DCsf1r-Gal4VP16/UAS-ECFP) transgene with a 150 bp
segment of the distal Csf1r promoter deleted, termed DCsf1r-
ECFP, has provided a novel tool to support in vivo imaging of
monocyte trafficking (30, 31), because expression was lost from
the large majority of tissue macrophages but remained in blood
monocytes, microglia, Langerhans cells, and cDC2 (32). In par-
ticular, dual reporter mice, such as those generated by crossing the
Cx3cr1-EGFP and Ccr2-RFP mice, have been valuable tools for
visualizing monocyte subsets and their differentiation in the brain
and liver (33), findings that would not have been obtainable using
single reporter mice. However, many other macrophage and
nonmacrophage reporter genes use EGFP, rendering the original
Csf1r-EGFP transgene of limited use for this purpose. Thus, ad-
ditional monocyte/macrophage reporter mice that are compatible
with existing EGFP-based reporters are needed.
Hence, we have created new tools and assays to image and assess
Csf1r gene and protein expression that can be combined conve-
niently with common fluorophores, EGFP transgenes, and the
DCsf1r-ECFP transgene for use in imaging and flow cytometry. In
particular, we characterize a new Csf1r-mApple line expressing
the red reporter gene mApple under the same promoter used in the
Csf1r-EGFP reporter, and apply this in combination with the
DCsf1r-ECFP transgene, lineage tracing, and labeled CSF1-Fc
and CSF1 proteins to distinguish different cellular compartments
within the MPS, and to dissect the homeostatic roles of CSF1.
Materials and Methods
Plasmid constructs
The 7.2 kb Csf1r reporter construct previously used to generate the Csf1r-
EGFP mice (26) was digested with ApaI and SalI (NEB) to remove EGFP
before gel purification using the QIAquick gel extraction kit (Qiagen).
Overhangs were removed with Mungbean nuclease (NEB) and DNA was
purified using QIAGEN MinElute columns (Qiagen), then dephosphory-
lated using thermosensitive alkaline phosphatase (Promega). A construct
encoding the fluorescent protein Csf1r-mApple (34) was digested with
SmaI and AflII, similarly purified, and overhangs removed before both
constructs were precipitated with EtOH/NaOAc and then ligated with T4
ligase (NEB) at 16˚C overnight. The resulting Csf1r-mApple construct was
transformed into DH5a competent cells. The Csf1r-rtTA-M2 construct
utilizing the same 7.2 kb mouse Csf1r promoter region was used previ-
ously to generate Csf1r-rtTA transgenic mice (35) For generation of
transgenic mice, plasmid backbones were removed by digestion with DrdI/
PvuI (Csf1r-mApple, NEB) and SalI/MluI (Csf1r-rtTA, Promega/NEB)
and then gel-purified using a QIAquick gel extraction kit. DNA was then
further purified using AMPure XP beads (Agencourt) according to the
instructions.
Generation of transgenic mice and animal maintenance
Animal experiments were permitted under license by the U.K. Home Office,
and were approved by the University of Edinburgh Animal Welfare and
Ethical Review Body. All mice including wild-type (WT) C57BL/6JOlaHsd
CD45.2+, congenic CD45.1+CD45.2+, Csf1r-EGFP (26), DCsf1r-
Gal4VP16/UAS-ECFP (36), and Ccr22/2 (37) lines were bred and housed
in specific-pathogen free facilities at the University of Edinburgh. Csf1r-
mApple/Csf1r-rtTA transgenic mice were generated at the University of
Edinburgh’s Central Biological Services Transgenic Core facility by mi-
croinjection of transgenes into the pronuclei of fertilized oocytes from
C57BL/JOlaHsd mice. The integration of the transgenes was determined
by PCR analysis of genomic DNA isolated from ear biopsy using primers
that amplified a 565 bp product between the c-fms promoter and rtTA
gene, and a 507 bp product between the c-fms promoter and Csf1r-mApple
gene, using primers 59-TTC CAG AAC CAG AGC CAG AG-39 (forward)
and 59-CTG TTC CTC CAATAC GCA GC-39 (reverse), and 59-CCTACA
TGT GTG GCTAAG GA-39 (forward) and 59-CTT GAA GTA GTC GGG
GAT GT-39 (reverse), respectively, and amplification temperatures of 35
cycles of 30 s at 94, 55, and 72˚C, after an initial denaturing step of 94˚C
for 5 min. Expression of Csf1r-mApple was verified by screening 10 ml
blood for the presence of Csf1r-mApple fluorescence by flow cytometry.
One founder positive for both transgenes transmitted the transgenes to
progeny and established the Csf1r-mApple/Csf1r-rtTA line (referred to as
Csf1r-mApple). The Csf1r-mApple line was maintained by breeding to
C57BL/6JOlaHsd mice, or where specified, bred to the DCsf1r-ECFP line,
for which subsequent analysis was performed on F1 progeny. For main-
tenance of the Csf1r-mApple line, transgenic progeny were initially
identified by PCR analysis of genomic DNA and flow-cytometric assess-
ment of the presence of Csf1r-mApple in blood cells, and subsequently by
flow cytometry alone. For identification of myeloid populations replen-
ished by CCR2-dependent bone marrow (BM) precursors, tissue-protected
BM chimeric mice were generated as previously described (23). Briefly,
anesthetized C57BL/6 CD45.1+CD45.2+ congenic mice were exposed to a
single dose of 9.5 Gy g-irradiation, while all but the hind legs and lower
abdomen were protected by a 2 inch lead shield. Animals were subse-
quently given 2–5 3 106 BM cells from CD45.2+ C57BL/6J mice or
Ccr22/2 animals by i.v. injection before being left for 8 wk prior to
analysis of chimerism in the tissue compartments. All experiments were
performed with age- and sex-matched littermate control mice and ap-
proved by the University of Edinburgh Animal Welfare and Ethical Review
Body under license granted by the U.K. Home Office.
Tissue digestion and FACS analysis
Unless otherwise stated, mice were culled by a rising concentration of CO2.
Then 100 ml of blood was collected by cardiac puncture into EDTA tubes.
The peritoneal cavity was lavaged with RPMI 1640 containing 2 mM
EDTA and 10 mM HEPES (Invitrogen). Cadavers were subsequently
perfused and lung and liver removed and chopped finely, and digested in
prewarmed collagenase mixture [0.625 mg ml21 collagenase D (Roche),
0.85 mg ml21 collagenase V (Sigma-Aldrich), 1 mg ml21 dispase (Life
Technologies, Invitrogen), and 30 U ml21 DNase (Roche Diagnostics) in
RPMI 1640] for 22 and 45 min respectively in a shaking incubator at 37˚C
before being passed through a 100 mm filter. Lung preparations were
washed in PBS containing 2 mM EDTA (Life Technologies, Invitrogen)
and 0.5% BSA (Sigma-Aldrich), termed FACS buffer, followed by cen-
trifugation at 300 g for 5 min, whereas liver preparations were washed in
50 ml then 30 ml of ice-cold RPMI 1640 followed by centrifugation at
300 g for 5 min. Erythrocytes in tissues and blood were lysed using RBC
lysis buffer from Sigma-Aldrich or BioLegend, respectively. All cells were
maintained on ice until further use. Cellular content of the preparations
was assessed by cell counting using a CASY TT counter (Roche). Equal
numbers of cells or equivalent volumes of blood were stained with Zombie
Aqua viability dye (Invitrogen) blocked with 0.025 mg anti-CD16/32
(2.4G2; BioLegend) and 1:10 heat-inactivated mouse serum (Invitrogen),
and then surface stained with a combination of Abs in FACS buffer. The
following Abs were used: F4/80 (BM8), Siglec-F (E50-2440), Siglec-F
(ES22-10D8), Ly6C (HK1.4), CD11b (M1/70), CD11c (N418), MHCII
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(M5/114.15.2), CD19 (6D5), CD3 (17A2), CD3 (17A2), CSF1R (AFS98),
CD45.1 (A20), CD45.2 (104), CD226 (10E5), CD64 (X57-5/7), Ly6G
(1A8), CD26 (H194-112), and PDCA-1 (927) (eBioscience, Miltenyi
Biotec, or BD Europe). Where applicable, cells were subsequently stained
with streptavidin-conjugated fluorochromes. Fluorescence minus one
controls confirmed gating strategies, whereas discrete populations within
lineage-negative cells were confirmed by omission of the corresponding
population-specific Ab. Samples were acquired on an LSRFortessa flow
cytometer (Becton Dickinson) at the Queens Medical Research Institute
Flow Cytometry and Cell Sorting Facility and resulting data were analyzed
using FlowJo V9 software. CD45+ cells were identified as live single cells
by excluding 7AAD+ or Zombie Aqua+ cells and using forward scatter area
versus forward scatter height characteristics. Cells positive for CD19,
CD3, Ly6G, and SiglecF, or CD19, CD3, and Ly6G were referred to as
Lineage+ and were excluded prior to analysis of liver, blood and cavity
cells, or lung cells, respectively, as shown in the respective figures.
For the processing of brain tissue, double transgenic mice were perfused
transcardially with physiological saline and brains were removed for re-
gional dissection into cerebellum, cortex, hippocampus, and striatum.
Mixed brain cell homogenates were prepared as described (32). The single-
cell suspension of each region was incubated with 1 mg ml21 anti-CD16/
32 and subsequently stained with rat anti-mouse/human CD11b (M1/70)
and rat anti-mouse CD45 (BioLegend). Flow cytometry was acquired us-
ing the Fortessa 320 (Becton Dickinson) and resulting data were analyzed
using FlowJo V10 software.
Inhibition of CSF1R signaling
The CSF1R kinase inhibitor GW2580 (LC Laboratories) was suspended in
0.5% hydroxypropylmethylcellulose and 0.1% Tween 20 using a Teflon
glass homogenizer. Diluent control or 160 mg/kg GW2580 was adminis-
tered daily for 4 d by oral gavage before mice were culled on day 5.
Alexa Fluor 647–labeled CSF1 and anti-CSF1R mAb
Preservative-free sterile anti-CSF1R mAb (clone AFS98) was purchased
from Bioserv (Sheffield, U.K.). Porcine CSF1 and CSF1-Fc was prepared as
described previously (12). CSF1 and CSF1-Fc were conjugated to Alexa
Fluor 647 (AF647) using the AF647 Microscale Protein labeling kit from
Thermo Fisher Scientific according to manufacturer’s instructions, and
sodium azide subsequently removed using 7k MWCO Pierce polyacryl-
amide spin desalting columns (Thermo Fisher Scientific). Mice were in-
jected i.v. with 0.5 mg anti-CSF1R mAb or PBS vehicle control, followed
by 5 mg CSF1-FcAF647 or PBS vehicle i.v. 10 min later. After a further 10
min, 60 ml of blood was removed by tail venipuncture, with the animals
then immediately culled by cervical dislocation, and tissues perfused with
PBS through the inferior vena cava. For study of CSF1 uptake in the
peritoneal cavity, mice were injected i.p. with or without 0.5 mg AFS98
followed by 0.5 mg CSF1AF647 or PBS vehicle 2 min later, and then culled
10 min later by exposure to increasing levels of CO2. The degree of
CSF1R-dependent uptake of CSF1AF647 or CSF1-FcAF647 is presented as
the D median fluorescence intensity (MFI) calculated as the MFI for in-
dividual samples from mice given labeled CSF1 minus the average MFI
from all samples pretreated with AFS98.
Imaging of tissues and cells
Whole-mount imaging of freshly isolated tissues from transgenic and WT
littermate control mice aged 12–15 wk was performed using a Zeiss
AxioZoom.V16 fluorescence microscope. Immediately after excision, tis-
sues were kept at 4˚C and protected from light. The fluorescent signal was
acquired at 500–550 and 590–650 nm for EGFP and Csf1r-mApple, re-
spectively. Acquisition of tissue background signal was performed by
imaging WT tissue with the filter used for detection of the Csf1r-mApple
protein.
Ex vivo confocal imaging of tissues
Male transgenic or WT male littermates were anesthetized, as per regu-
lations, and intravenously injected in the tail vein with 5 mg/g of weight of
Lectin-I [from Griffonia (Bandeiraea) simplicifolia] tagged with FITC
(Vector Labs). After 10 min, mice were perfused transcardially with HBSS
(Thermo Fisher Scientific), at a rate of 10 ml per min, and the left lobe of
the liver was excised. Lungs were inflated with a solution containing 1%
low melting-point agarose (Sigma-Aldrich) and, upon agarose solidifica-
tion, the left lung was excised. Detection of functional CSF1R in lung
myeloid subsets was performed by administering 5 mg CSF1-FcAF647 and
5 mg/g of weight of Lectin-I via i.v. injection. Mice were perfused with
HBSS, previous to lung excision and inflation with agarose, as described.
After dissection, liver and lung were placed on coverslip-bottom chambers
and covered with a sufficient volume of HBSS to prevent the surface of
tissues from drying. Chambers were kept on ice and protected from light
until tissues were imaged on a Zeiss LSM 710 microscope. Laser wave-
lengths for ECFP, FITC, and mApple were 405, 488, and 543 nm, re-
spectively. Fluorescence acquisition for ECFP, FITC, and mApple signals
in liver and lung was 400–480, 525–600, and 602–758 nm, respectively.
Acquisition settings for lung tissue treated with CSF1-FcAF647 were 400–
479, 525–583, 593–651, and 651–755 nm for ECFP, FITC, mApple, and
AF647, respectively. Postprocessing of images was performed by adjusting
the black/white thresholds in the software ZEN 2012 (blue edition) de-
veloped by Carl Zeiss as follows: ECFP: 0–175, FITC: 0–100, mApple:
0–75, AF647: 0–200.
Statistics
Statistical tests detailed in the figure legends were performed using
GraphPad Prism 6. Where necessary, data were log-transformed to achieve
equal variance.
Results
Generation of Csf1r-mApple mice
C57BL/6 mouse embryos were comicro-injected with a construct
containing the 7.2 kb Csf1r promoter region used to create the Csf1r-
EGFP mice (26) upstream of mApple, along with a construct
encoding the reverse tetracycline inducible transactivator rtTA-m2
under control of the same promoter (Csf1r-rtTA), previously used to
generate a Csf1r-driven Tet-on system (35). mApple was used be-
cause it is brighter than its parent mCherry, refractory to photo-
bleaching (38), suffers little from background autofluorescence, and
previously enabled whole-mount imaging of the avian response to
CSF1 in Csf1r-mApple reporter chickens (39). A single founder
positive by PCR for both transgenes and for mApple protein in blood
cells by flow cytometry was mated with a WT C57BL/6 mouse to
establish the Csf1r-mApple line. PCR analysis across 77 mice
revealed that Csf1r-mApple and Csf1r-rtTA transgenes were exclu-
sively coinherited, suggesting cointegration (data not shown). PCR
and flow cytometry analysis of blood demonstrated the Csf1r-mApple
transgene to be inherited at a frequency of 44.0% (n = 207). The
utility of the cointegrated Tet-on cassette is under investigation and is
not considered further in this study but preliminary data demonstrate
rtTA-m2 mRNA is expressed in peritoneal cells (data not shown).
Comparison of Csf1r-EGFP and Csf1r-mApple expression
across tissue
In whole-mount fluorescence microscopy of live organs from Csf1r-
mApple mice expression patterns of mApple recapitulated EGFP in
Csf1r-EGFP transgenic mice (Fig. 1A–F). Large stellate mApple+
cells were observed throughout the liver, lung, epidermis, and car-
diac muscle. Both transgenic strains highlighted the abundant
macrophage populations of the intestinal lamina propria (Fig. 1E),
and the red pulp of spleen (Fig. 1F) (26). Background fluorescence
in littermate control mice was negligible (Fig. 1A–F, left panel).
The Csf1r-EGFP and DCsf1r-ECFP transgenes have been used
extensively for in vivo imaging with multiphoton and spinning disc
microscopes (e.g., Refs. 20, 30, 31, 40–43), providing high-
resolution analysis of macrophage motility and the extent of their
ramified processes. Multiphoton imaging of whole mounts of the
muscularis externa of the intestine demonstrated the high signal-to-
noise ratio obtainable with the Csf1r-mApple reporter (Fig. 1G),
enabling visualization of the regular network of microglial-like
macrophages in this site (44, 45). Furthermore, the impact of ex-
ogenous CSF1-Fc, which regulates the function of these cells (44),
could be directly visualized as an increase in cell size.
Csf1r-mApple expression by blood myeloid cells
To determine efficiency, reliability, and specificity of transgene
expression, flow cytometry was performed on the blood of a
The Journal of Immunology 3
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cohort of Csf1r-mApple mice and littermate controls. Circu-
lating CSF1R+CD11b+ monocytes (Fig. 2A) were uniformly
Csf1r-mApple+ in both Ly6C+ and Ly6C2 subsets (Fig. 2B,
2C). As reported for the expression of EGFP in Csf1r-EGFP
mice, neutrophils and eosinophils, which express Csf1r mRNA
but not protein (46), were also Csf1r-mApple positive (Fig. 2B,
2C). The Csf1r promoter is active in B cells, which like mac-
rophages, express the key transcription factor, PU.1, albeit at
lower levels (47). Accordingly, ∼70% of B cells had very low,
but detectable, Csf1r-mApple (Fig. 2B, 2C). Similar expression
of EGFP in Csf1r-EGFP mice is not detectable by confocal
microscopy on spleen sections (46). The intensity of Csf1r-
mApple expression was consistent between animals, with
equivalent levels expressed by monocytes and neutrophils and
lower levels in eosinophils and B cells (Fig. 2D). Hence, the
pattern of Csf1r-mApple expression reproduced that reported
for EGFP in Csf1r-EGFP mice.
The level of Csf1r-mApple expression distinguishes monocytes,
macrophages, and cDC in different tissues
To determine if transgene expression distinguished cDC and
macrophages across multiple tissues, we first confirmed the identity
of marker-defined MPS populations before surveying transgene
expression in Csf1r-mApple mice. In the peritoneal cavity, we
have demonstrated that recruited monocytes continuously re-
plenish rare short-lived F4/80lo MHCII+ macrophages that include
both CD11c+ and CD11c2 cells (23), although only slowly
replacing the more abundant F4/80hi resident macrophages of
embryonic origin (23). Both CD11c+ and CD11c2 short-lived and
F4/80hi peritoneal macrophage populations express detectable
surface CSF1R. In contrast, Flt3-dependent cavity cDC of non-
monocyte BM origin also express CD11c+ and MHCII+ and can
be found among F4/80lo/2 cells, but can be distinguished as
CSF1R2 (23, 24, 48, 49). Based upon this published gating
strategy and previously assigned ontogenies (Fig. 3A) (23), Csf1r-
mApple was detected in Ly6C+ monocytes, all macrophage pop-
ulations, and in CD11b2 cDC1 and CD11b+ cDC2 (Fig. 3B, 3C)
(24). There was a progressive increase in Csf1r-mApple intensity
between Ly6C+ monocytes, CD11c-defined subsets of short-lived
F4/80loMHCII+ macrophages, and long-lived F4/80hi macro-
phages (Fig. 3D), consistent with the linear developmental rela-
tionship between these populations and monocytes in adult mice
(23, 48, 50). Csf1r-mApple fluorescence in both CD11b2 cDC1
and CD11b+ cDC2 was lower than in monocytes (Fig. 3D), con-
sistent with the lack of surface CSF1R (Fig. 3A). EGFP expres-
sion in Csf1r-EGFP mice replicated this pattern (Fig. 3E, 3F).
In the lung, alveolar macrophages are readily identified based
upon high levels of CD11c and SiglecF (Fig. 4A) (51, 52). In-
terstitial cells are more heterogeneous. Some MHCII+ cells with
varying levels of CD11c have been defined as macrophages based
upon their expression of the Fc receptor CD64 and CSF1R de-
pendence (51, 53), which contrasts the Flt3 dependence of CD642
interstitial cDC2 (15). To verify that CD64 expression distin-
guishes pulmonary interstitial macrophages from CD11b+ cDC2,
we assessed the turnover kinetics of CD64-defined MHCII+ cells
and their dependence on CCR2, an established method for de-
termining the likely monocyte dependence of tissue MPS cells
(23, 54). We used a BM chimeric system in which WT mice were
irradiated with organs of interest shielded to prevent irradiation-
induced injury and reconstituted with congenic WT or Ccr22/2
BM. This approach results in stable nonhost chimerism in blood
leukocytes of ∼30% in recipients of WT BM (23, 55) (Fig. 4B,
short-dashed line) and allows the turnover kinetics of tissue
populations to be assessed. Importantly, in recipients of Ccr22/2
BM chimerism in monocytes (Fig. 4B, long-dashed line) but not
other circulating leukocytes is largely abolished (23). Notably,
putative CD642CD11b+MHCII+ cDC2 were completely replaced
within 8 wk, consistent with the short half-life of DCs (14).
This occurred in a completely CCR2-independent manner, with
identical chimerism in recipients of WT and Ccr22/2 BM
(Fig. 4B). In contrast, relatively few CD64+MHCII+ cells were
replaced over 8 wk, although this was completely dependent on
CCR2, suggesting slow replenishment from monocytes. Thus,
consistent with previous work (15), CD64 accurately defines
distinct CD11b+ MPS populations. Alveolar macrophages showed
no evidence of chimerism (Fig. 4B), consistent with self-
maintenance (52, 56, 57). Surprisingly, replenishment of cells
FIGURE 1. Distribution of the Csf1r-mApple and Csf1r-EGFP transgenes
is similar throughout tissues. Whole-mount imaging of freshly isolated liver
(A), lung (B), skin epidermis (C), cardiac muscle (D), jejunum (E), and cross-
section of spleen (F) from WT (left panel), Csf1r-mApple (central), and
Csf1r-EGFP (right panel) mice, or from muscularis (G) of Csf1r-mApple
mice treated with PBS (left panel) or CSF1-Fc (right panel). In (C), a region
of interest has been further magnified to better show Langerhans cells (white
arrows), and hair follicles can be detected as highly autofluorescent struc-
tures (white circles). Scale bars in skin represent 100 mm; 200 mm in liver,
spleen, and cardiac muscle; 500 mm in lung and jejunum; and 10 mm in the
muscularis.
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defined as cDC1 was also dependent upon CCR2. However, these
cells express CCR2 within the lung environment (58) and thus
may require this receptor for tissue retention. Based upon the
verified ontogenies, Ly6C+ monocytes, CD64+ interstitial macro-
phages, and alveolar macrophages in the lungs were all Csf1r-
mApple+ (Fig. 4C, 4D), but expression increased progressively
between monocytes and mature macrophages (Fig. 4C, 4E). Both
cDC populations also expressed Csf1r-mApple, but at lower levels
than monocytes (Fig. 4C–E).
In the liver, the largest phagocyte population is the Kupffer cells
(KC), but a minority CD11b+F4/80lo BM-derived population may
include monocytes, cDC2, and possibly F4/80lo BM-derived
macrophages (14, 29, 57). KCs [F4/80hiCD11blo (29, 59, 60)]
(Fig. 5A) exhibited uniformly high expression of Csf1r-mApple
(Fig. 5B–D). The minority CD11b+F4/80lo compartment was
subdivided based upon Ly6C and MHCII (Fig. 5A). The Ly6C+
cells and Ly6C2MHCII2 cells resembled Ly6C+ and Ly6C2
blood monocytes in size and marker expression (Fig. 5F). Unlike
blood monocytes, MHCII+ cells among CD11b+F4/80lo cells were
larger, exhibited high levels of CD11c, and must include the Flt3-
dependent CSF1R-independent CD11b+ cDC2 described previ-
ously (14); hence, we provisionally assigned these cDC2 (Fig. 5F).
All CD11b+ populations expressed high levels of Csf1r-mApple
(Fig. 5B, 5C). In the same CCR2-dependent tissue-protected BM
chimera system used for the lung, the putative CD11b+ cDC2
population was replenished almost entirely by CCR2-independent
BM precursors (Fig. 5E). They also expressed the highest levels of
CD26, a marker of cDC conserved across species (61), and were
negative for CD64 (Fig. 5F), confirming them as cDC2. CD11b2/lo
F4/802 cells were also positive for Csf1r-mApple, but expressed
markers of cDC1 (Ly6C2MHCII+CD11c+CD26+) and plasmacy-
toid DC (pDC) (Ly6C+MHCII+PDCA-1+) (Fig. 5A, 5F), and were
replenished by CCR2-independent precursors (Fig. 5E). Hence, in
liver the Csf1r transgene did not distinguish cDC from monocytes,
but was highest in mature macrophages.
Detection of functional CSF1R using fluorescent CSF1-Fc
Csf1r mRNA may be posttranscriptionally regulated (62) and the
protein may be cleaved from the cell surface in response to TLR
signals (63). To assess functional CSF1R expression, we investi-
gated the ability of MPS cells to take up labeled pig CSF1-Fc
fusion protein, which produces a large increase in tissue macro-
phage populations when injected into mice (12) or pigs (64).
CSF1-Fc conjugated with AF647 (CSF1-FcAF647) was found to
bind specifically to monocytes in vitro (65). CSF1-FcAF647 was
injected intravenously 10 min before mice were sacrificed. In the
liver, the uptake of CSF1-FcAF647 was detected in KC, monocytes,
and cDC2, but not in cDC1, pDC (Fig. 6A, 6B), or neutrophils
(data not shown). Within cDC2, CSF1-FcAF647 binding was
prevalent in CD11chi cells (Fig. 6C) precluding any possible
confusion with the CD11cdim MHCII+ subcapsular macrophages
described recently (42). In the lung, the majority of Ly6C+
monocytes and interstitial macrophages bound CSF1-FcAF647,
whereas both cDC populations were negative (Fig. 6A, 6B). Up-
take of labeled CSF1-Fc by myeloid populations was reduced or
abolished by the anti-CSF1R Ab, AFS98 (Fig. 6A, 6B), a weak
inhibitor of receptor-ligand binding (66), and an identical labeling
profile was observed following injection of a non–Fc-fused
AF647-labeled porcine CSF1 (CSF1AF647) (data not shown).
No detectable CSF1-FcAF647 was bound by alveolar macrophages
(Fig. 6A, 6B) and these cells also failed to bind appreciable levels
in vitro (data not shown). Labeled anti-CD45 Ab was able to
access all other myeloid populations in lung (data not shown) (67)
and liver (Fig. 6D), suggesting a lack of CSF1-FcAF647 or
CSF1AF647 uptake by certain cDC reflects an absence of surface
CSF1R expression rather than the inaccessibility of the sites they
may occupy (31, 53).
Consistent with previous population-level data on CSF1 clear-
ance (68), KC bound the highest level of labeled CSF1 per cell in a
receptor-dependent manner (Fig. 6B), and considerably more per
FIGURE 2. Csf1r-mApple transgene expression in blood leukocytes. (A) Flow cytometric strategy to identify blood leukocytes. (B) Expression of Csf1r-
mApple in venous blood leukocytes from a representative Csf1r-mApple (right) and WT littermate control (left) mouse. (C) Frequency of cells positive for
Csf1r-mApple and (D) geometric mean fluorescence intensity (GeoMFI) of Csf1r-mApple gated on Csf1r-mApple+ cells for different blood leukocytes.
(B–D) Representative data from one of three experiments. Data are presented as mean 6 SD of four mice (C and D).
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cell than blood monocytes (Fig. 6E). In turn, Ly6C+ monocytes in
lung and liver were more intensely labeled than interstitial lung
macrophages or liver CD11b+ cDC2 and liver Ly6C2 monocytes
(Fig. 6B), although distinct intravascular versus parenchymal lo-
cations of these cells (31, 53) means exposure to circulating CSF1
cannot be controlled in this comparison. Of note, Ly6C+ blood
monocytes, identified independently of CSF1R expression
(Supplemental Fig. 1A), were more intensely labeled than the
Ly6C2 subset (Fig. 6E), despite equivalent surface expression of
CSF1R (Fig. 6F) (69, 70). Thus, novel differences in capacity to
bind CSF1 were revealed using this ligand-binding approach.
The relationship between Csf1r-mApple activity and CSF1R-
mediated ligand uptake was also examined in the peritoneal cavity
following i.p. injection. Monocytes and CD11c+ and CD11c2F4/
80loCD226+ macrophages (49, 50) were identified as described in
Supplemental Fig. 1B, avoiding the use of Abs to CSF1R. Neither
Csf1r-mApplelo cDC population bound appreciable levels of
CSF1AF647, whereas all three macrophage populations had higher
levels of receptor-dependent uptake of CSF1AF647 than Ly6C+
cavity monocytes (Fig. 7A). Surprisingly, the CD11c2F4/80lo
macrophages exhibited the greatest uptake. These differences
were not explained by differential levels of receptor-independent
macropinocytosis as uptake of injected OVA–Texas Red was
largely equivalent between populations (Fig. 7B). Anti-CSF1R
mAb inhibited CSF1 uptake to a similar degree in each pop-
ulation, with a reduction between 63 and 75%. The difference in
receptor activity appeared to have functional significance, as
treatment of mice daily for 4 d with a CSF1R kinase inhibitor,
GW2580 (71), which has been shown to inhibit proliferation of
microglia (41) and pleural macrophages (11), partly depleted the
CD11c2 subset of F4/80loMHCII+ peritoneal macrophages alone
(Fig. 7C, left graph), despite inhibiting proliferation (as evidenced
by Ki67 staining) of all macrophage populations (Fig. 7C, right
graph).
Csf1r-mApple:DCsf1r-ECFP mice allow in situ imaging of
distinct mononuclear phagocytes
The DCsf1r-ECFP transgene was crossed previously to the
Cx3cr1+/gfp or Itgax (CD11c)-EYFP mouse to distinguish pul-
monary monocytes from other myeloid lung populations (31). To
determine the utility of the Csf1r-mApple mouse to facilitate
in vivo imaging of different myeloid populations, we crossed it to
FIGURE 3. Csf1r transgene and CSF1R protein expression in the peritoneal cavity. (A) Flow cytometric strategy to identify peritoneal cavity myeloid
cells as recently described (23). (B–D) Expression of Csf1r-mApple in peritoneal cavity myeloid populations determined by flow cytometry, showing a
representative WT littermate control (left) and Csf1r-mApple (right) mouse (B), and graphs depicting the mean frequency of Csf1r-mApple+ cells in each
population (C) and geometric mean fluorescence intensity (GeoMFI) of Csf1r-mApple for different peritoneal leukocytes gated on Csf1r-mApple+ cells (D).
(E and F) Expression of Csf1r-EGFP in peritoneal cavity myeloid populations from Csf1r-EGFP mice, showing a representative flow cytometric overlay (E)
and graphs depicting the frequency and GeoMFI of Csf1r-EGFP+ cells in each population (F) across multiple mice. Representative data from one of three
experiments (B–D) or a single experiment (E and F). Data are presented as mean 6 SD of four mice (C, D, and F).
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the DCsf1r-ECFP line (32, 36). As in the intestine (32), the ma-
jority of cDC1, cDC2, and Ly6C+ and Ly6C2 monocytes in the
liver expressed high levels of ECFP, whereas pDC expressed in-
termediate levels. Neutrophils, eosinophils, and lymphocytes were
negative (data not shown) as were F4/80hi KC (Supplemental Fig. 2A).
All ECFP+ cells expressed intermediate levels of mApple
(Supplemental Fig. 2B, cyan gate), whereas all mApplehi cells
were ECFP2 and represent KC (Supplemental Fig. 2B, red gate).
We combined the two Csf1r reporters with detection of endothelial
cells by injection of FITC-labeled Lectin I. In confocal images
the mApple+ cells were almost completely restricted to the liver
sinusoids (e.g., pink boxes), consistent with KC (Fig. 8). In con-
trast, ECFP+mApple+ double-positive cells were rarely detected
(e.g., white box), despite the presence of numerous ECFP+
mApple2 cells (e.g., yellow box) (Fig. 8). These data suggest the
intermediate levels of Csf1r-mApple expressed in ECFP+ cDC and
monocytes (Fig. 5B, Supplemental Fig. 2A) are apparently below
the threshold of detection of confocal imaging. This conclusion
was supported by only weak detection of mApple expression
when peripheral blood was imaged using identical microscope
settings (Supplemental Fig. 3A). The Csf1r-ECFP+ cells in the
liver (e.g., yellow box) were mainly detected outside the sinusoids
and likely include the subcapsular liver macrophages that also
express the DCsf1r-ECFP transgene (42). The high level of
mApple expression in KC therefore allows imaging of these cells
without detection of monocytes and other mApple+ cells in the
liver.
In the lung, interstitial macrophages and DCwere ECFP negative
(Supplemental Fig. 2C) whereas the majority of alveolar macro-
phages and Ly6C+ monocytes expressed ECFP, as reported pre-
viously (31, 32). Combined, all ECFP+ cells were mApple+
(Supplemental Fig. 2D, cyan gate) and encompassed alveolar
macrophages and Ly6C+ and Ly6C2 monocytes, whereas ECFP2
mApplehi cells (Supplemetal Fig. 2D, red gate) comprised
CD64+ interstitial macrophages and a minor fraction of ECFP2
alveolar macrophages. In confocal images of transverse lung
sections, parenchymal populations broadly divided into
rounded ECFP+mApple+ cells (Fig. 9, yellow box) consistent
with alveolar macrophages or interstitial migratory monocytes
(31, 67) and elongated stellar-shaped ECFP2mApple+ cells
(Fig. 9, white box). Injection of CSF1-FcAF647 into the double
transgenic mice selectively labeled the extravascular interstitial
ECFP2mApple+ cells (Supplemental Fig. 4, white box), visible as
punctate staining indicative of internalization of labeled ligand,
FIGURE 4. Lineage-restricted Csf1r-mApple transgene expression in the lung. (A) Flow cytometric strategy to identify lung leukocytes. (B) Frequency
of donor cells within each lung population from tissue protected BM chimeric mice 8 wk after receiving BM from WT (white) or Ccr22/2 (black) mice.
Mean donor chimerism for circulating Ly6C+ monocytes is presented as short- or long-dashed lines for recipients of WT or Ccr22/2 BM, respectively. (C)
Expression of Csf1r-mApple in lung leukocytes from a representative WT littermate control (left) and Csf1r-mApple (right) mouse. (D) Frequency of cells
expressing Csf1r-mApple and (E) geometric mean fluorescence intensity (GeoMFI) of Csf1r-mApple gated on Csf1r-mApple+ cells for different lung
leukocytes. Data are from one of two independent experiments. Data presented as mean6 SD of four mice (D and E) or mean 6 SEM of five mice (B). The
asterisk (*) indicates significant differences using multiple t tests corrected for multiple comparisons using the Holm–Sidak method.
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FIGURE 5. Csf1r-mApple transgene expression in the liver. (A) Flow cytometric strategy to identify liver leukocytes. (B) Expression of Csf1r-mApple in liver
leukocytes with histograms from a representative Csf1r-mApple (right) and WT littermate control (left) mouse. (C) Frequency of cells expressing Csf1r-mApple and (D)
geometric mean fluorescence intensity (GeoMFI) of Csf1r-mApple gated on Csf1r-mApple+ cells for different liver leukocytes. (E) Frequency of donor cells within each
hepatic population from tissue protected BM chimeric mice 8 wk after receiving BM fromWT (white) or Ccr22/2 (black) mice. Mean donor chimerism for blood Ly6C+
monocytes is presented as short- or long-dashed lines for recipients of WT or Ccr22/2 BM, respectively. (F) Representative histograms showing forward scatter area
(FSC-A) characteristics and CD26, CD11c, CD64, and PDCA1 expression (tinted) overlayed with FMO controls (open) for liver leukocytes and blood monocytes. (B–D)
Representative data from one of three or (E) two experiments, with data presented as mean6SD of four mice (C andD) or mean6SEM of five (E) mice. The asterisk (*)
indicates significant differences using multiple t tests corrected for multiple comparisons using the Holm–Sidak method.
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and confirmed them to be interstitial macrophages rather
than ECFP2mApplelo pulmonary DC. Many extravascular
ECFP+mApple+ cells also took up CSF1-FcAF647 (Supplemental
Fig. 4), most likely migratory monocytes identified previously by
live imaging (30, 31). In contrast, the most frequent cells ob-
served within the pulmonary capillaries were ECFP2mApple+
(Fig. 9D, cyan box) and failed to label with injected CSF1-
FcAF647 (Supplemental Fig. 4), consistent with pulmonary
neutrophils (72). Consistent with this, imaging of blood cells at
identical power settings confirmed strong detection of mApple
in ECFP+ monocytes and ECFP2 neutrophils (Supplemental
Fig. 3B).
Heterogeneous expression of Csf1r reporter genes in the brain
Macrophages in the mouse embryo are ECFP positive in the
DCsf1r-ECFP line from their earliest appearance in the yolk sac
(32). In addition to alveolar macrophages, one of the few locations
in adults in which transgene expression is retained is in microglia.
FIGURE 6. Tissue-specific con-
sumption of CSF1 by cDC2 in vivo.
(A) Histograms of AF647 fluorescence
of leukocyte populations from lung
and liver following i.v. injection of
anti-CSF1R mAb AF-S98 or PBS ve-
hicle before subsequent i.v. delivery of
CSF1-FcAF647 or PBS vehicle. (B)
Geometric mean fluorescence intensity
(GeoMFI) of AF647 of cells from
mice in (A) (left graph) and change in
MFI between mice given CSF1-
FcAF647 alone or after AFS-98 pre-
treatment (right graph), with data
presented as mean 6 SEM of four
mice per group (left), or with data
points for individual mice shown
(right). Data are from one of two re-
peat independent experiments. (C)
Representative plots showing CSF1-
FcAF647 uptake versus CD11c expres-
sion or FMO control on hepatic cDC2
from mice in (A). (D) PE fluorescence
of liver leukocytes from C57BL/6
mice injected i.v. with anti–CD45-PE
mAb or PBS vehicle 2 min prior to
necropsy, showing data from one rep-
resentative mouse of two per group.
(E) Histograms of AF647 fluorescence
of Ly6C+ and Ly6C2 blood monocytes
from mice treated as in (A) but given
CSF1AF647, and a graph showing
change in GeoMFI of blood mono-
cytes and liver KC between mice given
CSF1AF647 alone or after pretreatment
with AFS98, and a dot plot showing
Ly6C versus AF647 uptake on all
CD32CD192Ly6G2 blood cells with
data points representing individual
mice. (F) Conventional surface CSF1R
(CD115) and Ly6C staining on CD32
CD192Ly6G2 blood cells from naive
mice. Data are from one representative
experiment of two (B–D and F) or
three (E) independent repeats. The as-
terisk (*) indicates significant differ-
ences between CSF1-FcAF647 alone
and AFS98 + CSF1-FcAF647 using t
tests corrected for multiple compari-
sons with the Holm–Sidak method (B,
left graph), whereas lines indicate
significant differences using one-way
ANOVA (B, right graph).
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Grabert et al. (73) reported differences in microglia numbers and
gene expression profiles in different mouse brain regions, and
changes in gene expression with age. We used the Csf1r-mApple:
DCsf1r-ECFP cross to further dissect microglial heterogeneity in
different brain regions. CD45loCD11b+ classical microglia were
uniformly strongly positive for mApple (Fig. 10A). Like blood
monocytes and alveolar macrophages, microglia in cortex, hip-
pocampus, and striatum were largely positive for ECFP, but in the
cerebellum the percentage was much lower (37.4%, Fig. 10B).
The level of ECFP in these cells was also lower, and lacked a clear
peak, reminiscent of the ECFP profiles of macrophages and DC in
the gut (32). The brain also contains a separable CD11b+, CD45hi
macrophage-like microglial population, a subset of which oc-
cupies perivascular locations and expresses higher levels of Csf1r
than monocytes (74). By contrast to the classical microglia and
blood monocytes, the CD11b+CD45hi cells were .50% ECFP
negative in all brain regions (Fig. 10B).
Discussion
We have developed a novel Csf1r-mApple reporter line. The
Csf1r promoter construct used has been remarkably consistent
in generating location and copy-number–independent expression
of transgenes (75), further confirmed by the comparable pattern of
Csf1r-mApple and Csf1r-EGFP transgene expression. Expression of
Csf1r-mApple had no impact on numbers of tissue macrophages or
circulating blood leukocytes (data not shown). With optimal mi-
croscope settings, the distinct profile of transgene expression across
subsets of MPS cells allowed exclusive detection of mApplehi cells.
When combined with the DCsf1r-ECFP reporter gene, which se-
lectively labels subsets of Csf1r-positive cells, CSF1-Fc labeled
with AF647, and FITC-labeled Lectin, we could identify and image
lung interstitial macrophages and liver KC, and distinguish them
from other myeloid cells. Despite high levels of Csf1r-mApple and
Csf1r-EGFP (46) transgene expression, neutrophils are identifiable
by injection of labeled Abs to Ly6G, a molecule with a negligible
role in neutrophil trafficking or function (76, 77). Thus, there are
numerous possibilities to produce live images of macrophage be-
havior and heterogeneity, particularly by combining with other
established EGFP-based reporter mice.
In common with the Csf1r-EGFP reporter (78), Csf1r-mApple
expression was uniformly higher in resident macrophages com-
pared with monocytes, a difference reflected in the ability of at
FIGURE 7. Consumption of CSF1 differs between monocytes and resident peritoneal macrophage populations. (A) Representative histograms of AF647
fluorescence in cavity leukocytes 10 min after i.p. injection of CSF1AF647 or PBS vehicle alone or in combination with pretreatment with AFS98, and
graphs showing MFI of AF647 (right of histogram) and change in MFI between mice given CSF1AF647 alone or after AFS98 pretreatment (below his-
togram), with data presented as mean 6 SEM of three to four mice per group. Data are from one of three independent repeat experiments. (B) Repre-
sentative histograms of Texas Red fluorescence in cavity leukocytes 10 min after i.p. injection of OVA–Texas Red conjugate from a single experiment. (C)
Total number of cavity leukocytes and proportion expressing high levels of Ki67 from mice treated for 4 d with GW2580 (open) or vehicle control (closed),
with data points depicting individual mice. Data representative of two independent experiments. The asterisk (*) indicates significant differences using
multiple t tests corrected for multiple comparisons using the Holm–Sidak method.
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least liver and cavity macrophages to capture more CSF1 on a per-
cell basis than monocytes in vivo. Consistently, peritoneal mac-
rophages compete effectively for available CSF1 in mixed culture
with proliferating BM-derived macrophages (79). The rapid up-
take of CSF1AF647 by KC is consistent with their role in regulating
the circulating CSF1 concentration (68). Hence, upregulation of
CSF1R expression may be a general feature of macrophage dif-
ferentiation that allows them to compete for or control bioavail-
able CSF1. The apparent inability of alveolar macrophages to
capture CSF1 is a notable departure from this tenet. However,
alveolar macrophages are unaffected in adult CSF1-deficient op/
op mice (80) and their replenishment from BM following irradi-
ation is largely independent of CSF1R (81). Thus, our data are
consistent with a lack of role for CSF1 in maintenance of the
alveolar macrophage niche. However, it remains unclear why both
alveolar macrophages and granulocytes express high levels of
Csf1r transgene despite lacking a surface receptor. In the blood,
Ly6C+ monocytes more readily took up CSF1 than their Ly6C2
progeny, a feature consistent with the suggestion that Ly6C+
monocytes regulate the availability of CSF1, thereby controlling
the lifespan of the Ly6C2 population (57). Interestingly, higher
consumption of CSF1 by classical monocytes is also evident in
PBMCs from Csf1r-EGFP transgenic sheep (65), suggesting this
feature is conserved across species.
Intensity of fluorescence in Csf1r-mApple mice also largely
distinguished long-lived tissue-resident macrophages (KC, alveo-
lar macrophages, and F4/80hi peritoneal macrophages) from those
of more recent monocyte-origin (F4/80lo resident peritoneal and
lung interstitial macrophages) but was not correlated with the
ability to take up labeled CSF1. In the peritoneal cavity, the re-
ceptor activity was greatest in F4/80loCD11c2 cells. Notably,
these cells were selectively depleted following treatment with the
CSF1R kinase inhibitor GW2580. Dynamics of loss of labeled
histone 2B-GFP from peritoneal F4/80lo macrophages places the
half-life for replenishment of both CD11c+ and CD11c2 subsets
from monocytes at around 2 wk (23), much longer than the 4 d
treatment regimen in this study. Hence, selective loss of F4/80lo
CD11c2 cells likely results from reduced survival or retention in
FIGURE 8. Csf1r-mApple and DCsf1r-ECFP transgenes allow imaging
of distinct lineages of hepatic myeloid cells. Confocal image of the surface
of the left lobe of the liver of a DCsf1r-ECFP (A), Csf1r-mApple (B), WT
(C), and Csf1r-mApple/DCsf1r-ECFP (D) mouse imaged ex vivo. FITC-
Lectin I was injected i.v. to reveal liver sinusoidal endothelium. Scale bars
represent 20 mm (A–C) or 50 mm (D).
FIGURE 9. Csf1r-mApple and DCsf1r-ECFP transgenes allow imaging
of distinct lineages of pulmonary myeloid cells. Confocal image of a
transverse section of lung from a DCsf1r-ECFP (A), Csf1r-mApple (B),
WT (C), and Csf1r-mApple/DCsf1r-ECFP (D) mouse imaged ex vivo.
FITC-Lectin was injected i.v. to reveal pulmonary vasculature. Scale bars
in all panels represent 50 mm.
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the cavity rather than a failure of monocytes to differentiate and
replenish these cells. Both F4/80hi and F4/80lo populations of
peritoneal macrophages are rapidly lost upon Ab-mediated neu-
tralization of CSF1 (24), suggesting only partial blockade of
CSF1R signaling occurred with the oral inhibitor used in this
study. Higher levels of CSF1R signaling are generally required for
proliferation than survival of macrophages (8) and hence the
uniform inhibition of Ki67 expression observed across the peri-
toneal macrophage compartment is consistent with a reduction of
high-level CSF1R-signaling by GW2580 treatment. In light of
this, our data suggest the F4/80loCD11c2 subset require a higher
threshold of CSF1R signaling for survival and consequently
exhibit greater CSF1R activity. Thus, different populations of
peritoneal macrophages would appear to pursue distinct survival
strategies. Short-lived cells are more reliant on high levels of
CSF1 signaling, whereas long-lived cells are better adapted to
efficiently use CSF1, possibly explaining the predominance of the
latter under homeostatic CSF1-limited conditions (82). Either
way, our data reveal fine-tuning of CSF1R activity but not nec-
essarily Csf1r transgene or gene expression between distinct
macrophage populations.
Relatively low, or absent, expression of the Csf1r-mApple
reporter also provided a useful marker delineating peritoneal
and pulmonary CCR2-independent cDC from CCR2-dependent
CD11c+/2MHCII+ APC, likely of monocyte origin. Monocyte-
derived CD11c+ APC have also been described within the der-
mis, kidney, and gut (6, 21, 54, 83), in which tissue cDC also
expressed lower levels of Csf1r (22). In the liver, MHCII+
CD11c+ cells were largely replenished by CCR2-independent
BM precursors, uniformly expressed the candidate cDC
marker CD26, and lacked the candidate macrophage marker
CD64. Consistent with a cDC nature, these cells also uniformly
express the transcription factor Zbtb46 (84). Nevertheless, these
cells showed similar levels of Csf1r-mApple transgene expres-
sion to monocytes, and the CD11b+ cDC2 fraction bound la-
beled CSF1-Fc. Although juvenile Csf1r2/2 mice have normal
numbers of hepatic cDC2 (14), unlike in other tissues, these
cells also do not require CSF2 for survival (85), indicating
possible redundancy between these growth factors. In adult mice
the impact of Csf1 and Csf1r mutations are more apparent (86)
and anti-CSF1R treatment produced an almost complete deple-
tion of liver cells expressing a Csf1r-EGFP transgene (87).
Hence, in general, our data do not support an absolute division
between Csf1r and Flt3-dependent APC populations. By anal-
ogy with the functional diversity of classical macrophages in
different organs (51, 88–90), APC differentiation is likely also
organ specific. Because CSF1 drives a largely immunoregula-
tory program (91), the responsiveness of cDC2 to CSF1 may
underlie the relatively weak APC activity in liver (92) and
contribute to a tolerogenic environment in the liver (93). Simi-
larly, competition of CSF1R+ cDC2 together with KC and
classical patrolling monocytes (94) for available CSF1 could
provide an explanation for the relative absence of hepatic
monocyte-derived MHCII+ APC.
In adult mice, labeling of cDC and macrophages in the DCsf1r-
ECFP reporter is tissue specific (32). Using the DCsf1r-ECFP
transgene, we highlighted the utility of the Csf1r-mApple strain to
be crossed to existing reporter lines, visualizing distinct MPS
populations in the lung and liver. Moreover, combined analysis of
the Csf1r-mApple and DCsf1r-ECFP transgenes highlighted het-
erogeneity among microglia. Intriguingly, the percentages of
DCsf1r-ECFP negative microglia correlated with the retention of
microglia in the IL-34–knockout mouse in the same brain regions
(95). Similarly, in other tissues, ECFP expression occurs pre-
dominantly in locations where macrophages are more reliant on
IL-34 (for example, Langerhans cells) or CSF2 (alveolar macro-
phages). Hence, the graded expression of the DCsf1r-ECFP
transgene in microglia may reflect its induction during differen-
tiation or the proximity of individual cells to the tissue-specific
factors that control its expression.
In overview, the Csf1r-mApple mouse recapitulates the ex-
pression profile of the widely used Csf1r-EGFP reporter. In
combination with other reporters, and labeled CSF1, the Csf1r-
mApple mouse provides a new tool to dissect the differentiation
and function of the heterogeneous populations of mouse tissue
mononuclear phagocytes and the homeostatic roles of CSF1.
How different mononuclear phagocytes regulate CSF1R activity
remains an important question given the continued interest in
macrophages as possible vehicles for delivery of gene therapies
and as targets of therapeutics.
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FIGURE 10. The expression of Csf1r-mApple and DCsf1r-ECFP
transgenes in regional brain homogenates. Cerebellum, cortex, hippo-
campus, and striatum were processed to generate a single-cell suspension.
(A) Compared are CD11b+CD45lo microglia and CD11b+CD45hi cells of
the cerebellum and cortex regarding their expression of Csf1r-mApple and
ECFP. (B) Percentage of double transgene positive CD11b+CD45lo and
CD11b+CD45hi cell populations across all selected regions.
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